Optogenetics Actuators and Sensors Market Analysis Report By Product, By Disease Type (Retinal Disorders, Parkinson’s Disease, Schizophrenia, Autism, Depression & Anxiety), And Segment Forecasts, 2018 - 2025
This report can be delivered to the clients within 48 Business Hours
The global optogenetics actuators & sensors market size is expected to reach USD 584.73 million by 2025, according to a new report by Grand View Research, Inc., exhibiting a 1.93% CAGR during the forecast period. Extensive research in the field of neuroscience and ophthalmology is expected to boost market growth in the coming years. Key players are focusing majorly on research activities to study brain functions in various psychiatric and retinal disease states, which is anticipated to drive the sector.
Government organizations are providing funds to academic research institutions and individual researchers for advancements in the field of optogenetics. Moreover, various initiatives undertaken by international organizations such as WHO and NIH are anticipated to boost market growth. Various projects and initiatives initiated in the field of neuroscience are also promoting growth prospects.
In addition, ongoing investigations to improve signal sizes and responses and target specificity of subcellular membranes such as axon terminals, cell body, and dendrites in neuroscience are expected to support the growth of the segment. Rise in incidence of retinal and brain disorders are ultimately increasing demand for optogenetic actuators and sensors.
Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to drive technological progressions in optogenetics. This, in turn, is anticipated to significantly boost the growth of the optogenetics actuators and sensors market over the forecast period.
Further key findings from the report suggest:
The global optogenetics actuators & sensors market size is expected to reach USD 584.73 million by 2025, according to a new report by Grand View Research, Inc., exhibiting a 1.93% CAGR during the forecast period. Extensive research in the field of neuroscience and ophthalmology is expected to boost market growth in the coming years. Key players are focusing majorly on research activities to study brain functions in various psychiatric and retinal disease states, which is anticipated to drive the sector.
Government organizations are providing funds to academic research institutions and individual researchers for advancements in the field of optogenetics. Moreover, various initiatives undertaken by international organizations such as WHO and NIH are anticipated to boost market growth. Various projects and initiatives initiated in the field of neuroscience are also promoting growth prospects.
In addition, ongoing investigations to improve signal sizes and responses and target specificity of subcellular membranes such as axon terminals, cell body, and dendrites in neuroscience are expected to support the growth of the segment. Rise in incidence of retinal and brain disorders are ultimately increasing demand for optogenetic actuators and sensors.
Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to drive technological progressions in optogenetics. This, in turn, is anticipated to significantly boost the growth of the optogenetics actuators and sensors market over the forecast period.
Further key findings from the report suggest:
- Actuators are estimated to account for the largest revenue share owing to their increased usage in investigations related to neuroscience and ophthalmology
- Sensors are anticipated to grow at the fastest rate in the coming years due to technological advancements in optogenetics
- Retinal disorders accounted for the largest revenue share owing to higher usage of optogenetic actuators and sensors in disease oriented studies. Rise in prevalence of various retinal and psychiatric disorders is also anticipated to boost the segment
- North America dominated the market owing to government support, extensive research, local presence of substantial number of players, and well-established healthcare framework
- Asia Pacific is expected to exhibit the fastest growth over the forecast period owing to progressive industrialization and favorable government support
- Major players include Bruker; Circuit Therapeutics, Inc.; Gensight Biologics; AGTC; Prizmatix; Merck KGaA; Elliot Scientific Ltd; Coherent, Inc.; The Jackson Laboratory; Scientifica (Judges Scientific Plc Company); Addgene; Shanghai Laser & Optics Century Co., Ltd. (SLOC); Noldus Information Technology; Thorlabs, Inc.; and Danaher
- Companies are collaborating with academic institutions and private and public entities to accelerate developments in optogenetics.
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s Internal Database
1.2 Data Analysis
1.3 Market Formulation & Validation
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Growing use of optogenetics in the field of neuroscience
3.1.1.2 Government initiatives & funding opportunities
3.1.1.3 Rising burden of neurological & retinal disorders
3.1.2 Market restraint analysis
3.1.2.1 High cost of technology
3.1.2.2 Ethical regulations for animal welfare
3.2 Penetration & Growth Prospect Mapping for Methods, 2016
3.3 Optogenetics Actuators & Sensors Market-SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
3.4 Industry Analysis - Porter’s
CHAPTER 4 MARKET CATEGORIZATION: PRODUCTS ESTIMATES & TREND ANALYSIS
4.1 Global Optogenetic Actuators & Sensors Market: Product Movement Analysis
4.2 Actuators
4.2.1 Global actuators market, 2014 - 2025 (USD Million)
4.2.2 Channelrhodopsin
4.2.2.1 Global channelrhodopsin market, 2014 - 2025 (USD Million)
4.2.3 Halorhodopsin
4.2.3.1 Global halorhodopsin market, 2014 - 2025 (USD Million)
4.2.4 Archaerhodopsin
4.2.4.1 Global archaerhodopsin market, 2014 - 2025 (USD Million)
4.3 Sensors
4.3.1 Global sensors market, 2014 - 2025 (USD Million)
4.3.2 Genetically encoded calcium indicators
4.3.2.1 Global genetically encoded calcium indicators market, 2014 - 2025 (USD Million)
4.3.3 Voltage-sensitive fluorescent proteins
4.3.3.1 Global voltage-sensitive fluorescent proteins market, 2014 - 2025 (USD Million)
4.3.4 pH Sensors
4.3.4.1 Global pH sensors market, 2014 - 2025 (USD Million)
CHAPTER 5 MARKET CATEGORIZATION: DISEASE TYPE ESTIMATES & TREND ANALYSIS
5.1 Global Optogenetic Actuators & Sensors Market: Disease Type Movement Analysis
5.2 Retinal Disorders
5.2.1 Global retinal disorders market, 2014 - 2025 (USD Million)
5.3 Parkinson’s Disease
5.3.1 Global parkinson’s disease market, 2014 - 2025 (USD Million)
5.4 Anxiety & Depression
5.4.1 Global anxiety & depression market, 2014 - 2025 (USD Million)
5.5 Autism
5.5.1 Global autism market, 2014 - 2025 (USD Million)
5.6 Schizophrenia
5.6.1 Global schizophrenia market, 2014 - 2025 (USD Million)
5.7 Others
5.7.1 Global others market, 2014 - 2025 (USD Million)
CHAPTER 6 MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT & DISEASE TYPE
6.1 Global Optogenetics Actuators & Sensors Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 North America optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.2.2 North America optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.2.3 U.S.
6.2.3.1 U.S. optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.2.3.2 U.S. optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.2.4 Canada
6.2.4.1 Canada optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.2.4.2 Canada optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.3 Europe
6.3.1 Europe optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.2.2 Europe optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.3.3 Germany
6.3.3.1 Germany optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.3.3.2 Germany optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.3.4 U.K.
6.3.4.1 U.K. optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.3.4.2 U.K. optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.4 Asia Pacific
6.4.1 Asia Pacific optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.4.2 Asia Pacific optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.4.3 Japan
6.4.3.1 Japan optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.4.3.2 Japan optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.4.4 China
6.4.4.1 China optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.4.4.2 China optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.5 Latin America
6.5.1 Latin America optogenetic actuators & sensors market, 2014 - 2025 (USD Million) by product
6.5.2 Latin America optogenetic actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.5.3 Brazil
6.5.3.1 Brazil optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
6.5.3.2 Brazil optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.6 Middle East & Africa (MEA)
6.6.1 Middle East & Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.6.2 Middle East & Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.6.3 South Africa
6.6.3.1 South Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.6.3.2 South Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 List of Companies
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Elliot Scientific Ltd.
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Shanghai Laser & Optics Century Co., Ltd. (SLOC)
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.3 GenSight Biologic SA
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Danaher
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Cohorent, Inc.
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Thorlabs,Inc.
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Prizmatix Ltd.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Bruker
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Scientifica, A Judges Scientific plc Company
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Addgene
7.3.10.1 Financial performance
7.3.10.2 Product benchmarking
7.3.10.3 Strategic initiatives
7.3.11 The Jackson Laboratory
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 Noldus Information Technology
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Merck KGaA
7.3.13.1 Company overview
7.3.13.1.1 Sigma-Aldrich Co. LLC
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
7.3.13.4 Strategic initiatives
7.3.14 AGTC
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Strategic initiatives
7.3.15 Circuit Therapeutics, Inc.
7.3.15.1 Company overview
7.3.15.2 Financial performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s Internal Database
1.2 Data Analysis
1.3 Market Formulation & Validation
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Growing use of optogenetics in the field of neuroscience
3.1.1.2 Government initiatives & funding opportunities
3.1.1.3 Rising burden of neurological & retinal disorders
3.1.2 Market restraint analysis
3.1.2.1 High cost of technology
3.1.2.2 Ethical regulations for animal welfare
3.2 Penetration & Growth Prospect Mapping for Methods, 2016
3.3 Optogenetics Actuators & Sensors Market-SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
3.4 Industry Analysis - Porter’s
CHAPTER 4 MARKET CATEGORIZATION: PRODUCTS ESTIMATES & TREND ANALYSIS
4.1 Global Optogenetic Actuators & Sensors Market: Product Movement Analysis
4.2 Actuators
4.2.1 Global actuators market, 2014 - 2025 (USD Million)
4.2.2 Channelrhodopsin
4.2.2.1 Global channelrhodopsin market, 2014 - 2025 (USD Million)
4.2.3 Halorhodopsin
4.2.3.1 Global halorhodopsin market, 2014 - 2025 (USD Million)
4.2.4 Archaerhodopsin
4.2.4.1 Global archaerhodopsin market, 2014 - 2025 (USD Million)
4.3 Sensors
4.3.1 Global sensors market, 2014 - 2025 (USD Million)
4.3.2 Genetically encoded calcium indicators
4.3.2.1 Global genetically encoded calcium indicators market, 2014 - 2025 (USD Million)
4.3.3 Voltage-sensitive fluorescent proteins
4.3.3.1 Global voltage-sensitive fluorescent proteins market, 2014 - 2025 (USD Million)
4.3.4 pH Sensors
4.3.4.1 Global pH sensors market, 2014 - 2025 (USD Million)
CHAPTER 5 MARKET CATEGORIZATION: DISEASE TYPE ESTIMATES & TREND ANALYSIS
5.1 Global Optogenetic Actuators & Sensors Market: Disease Type Movement Analysis
5.2 Retinal Disorders
5.2.1 Global retinal disorders market, 2014 - 2025 (USD Million)
5.3 Parkinson’s Disease
5.3.1 Global parkinson’s disease market, 2014 - 2025 (USD Million)
5.4 Anxiety & Depression
5.4.1 Global anxiety & depression market, 2014 - 2025 (USD Million)
5.5 Autism
5.5.1 Global autism market, 2014 - 2025 (USD Million)
5.6 Schizophrenia
5.6.1 Global schizophrenia market, 2014 - 2025 (USD Million)
5.7 Others
5.7.1 Global others market, 2014 - 2025 (USD Million)
CHAPTER 6 MARKET CATEGORIZATION: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT & DISEASE TYPE
6.1 Global Optogenetics Actuators & Sensors Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 North America optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.2.2 North America optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.2.3 U.S.
6.2.3.1 U.S. optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.2.3.2 U.S. optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.2.4 Canada
6.2.4.1 Canada optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.2.4.2 Canada optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.3 Europe
6.3.1 Europe optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.2.2 Europe optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.3.3 Germany
6.3.3.1 Germany optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.3.3.2 Germany optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.3.4 U.K.
6.3.4.1 U.K. optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.3.4.2 U.K. optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.4 Asia Pacific
6.4.1 Asia Pacific optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.4.2 Asia Pacific optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.4.3 Japan
6.4.3.1 Japan optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.4.3.2 Japan optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.4.4 China
6.4.4.1 China optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.4.4.2 China optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.5 Latin America
6.5.1 Latin America optogenetic actuators & sensors market, 2014 - 2025 (USD Million) by product
6.5.2 Latin America optogenetic actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.5.3 Brazil
6.5.3.1 Brazil optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
6.5.3.2 Brazil optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.6 Middle East & Africa (MEA)
6.6.1 Middle East & Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.6.2 Middle East & Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
6.6.3 South Africa
6.6.3.1 South Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by product
6.6.3.2 South Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million) by disease type
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 List of Companies
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Elliot Scientific Ltd.
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Shanghai Laser & Optics Century Co., Ltd. (SLOC)
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.3 GenSight Biologic SA
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Danaher
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Cohorent, Inc.
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Thorlabs,Inc.
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Prizmatix Ltd.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Bruker
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Scientifica, A Judges Scientific plc Company
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Addgene
7.3.10.1 Financial performance
7.3.10.2 Product benchmarking
7.3.10.3 Strategic initiatives
7.3.11 The Jackson Laboratory
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 Noldus Information Technology
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Merck KGaA
7.3.13.1 Company overview
7.3.13.1.1 Sigma-Aldrich Co. LLC
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
7.3.13.4 Strategic initiatives
7.3.14 AGTC
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Strategic initiatives
7.3.15 Circuit Therapeutics, Inc.
7.3.15.1 Company overview
7.3.15.2 Financial performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
LIST OF TABLES
Table 1 Global number of DALY’s for neurological disorders for 2005, 2015, & 2030
Table 2 Optogenetic studies of neurodegenerative diseases
Table 3 Transgenic mouse lines expressing optical activators or silencers
Table 4 List of the latest GEVI’s apt for cardiac in vivo studies
Table 5 North America optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 6 North America actuators market, by product 2014 - 2025 (USD Million)
Table 7 North America sensors market, by product 2014 - 2025 (USD Million)
Table 8 North America optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 9 U.S. optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 10 U.S. actuators market, by product 2014 - 2025 (USD Million)
Table 11 U.S. sensors market, by product 2014 - 2025 (USD Million)
Table 12 U.S. optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 13 Canada optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 14 Canada actuators market, by product 2014 - 2025 (USD Million)
Table 15 Canada sensors market, by product 2014 - 2025 (USD Million)
Table 16 Canada optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 17 Europe optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 18 Europe actuators market, by product 2014 - 2025 (USD Million)
Table 19 Europe sensors market, by product 2014 - 2025 (USD Million)
Table 20 Europe optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 21 Germany optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 22 Germany actuators market, by product 2014 - 2025 (USD Million)
Table 23 Germany sensors market, by product 2014 - 2025 (USD Million)
Table 24 Germany optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 25 U.K. optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 26 U.K. actuators market, by product 2014 - 2025 (USD Million)
Table 27 U.K. sensors market, by product 2014 - 2025 (USD Million)
Table 28 U.K. optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 29 Asia Pacific optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 30 Asia Pacific actuators market, by product 2014 - 2025 (USD Million)
Table 31 Asia Pacific sensors market, by product 2014 - 2025 (USD Million)
Table 32 Asia Pacific optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 33 Japan optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 34 Japan actuators market, by product 2014 - 2025 (USD Million)
Table 35 Japan sensors market, by product 2014 - 2025 (USD Million)
Table 36 Japan optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 37 China optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 38 China actuators market, by product 2014 - 2025 (USD Million)
Table 39 China sensors market, by product 2014 - 2025 (USD Million)
Table 40 China optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 41 Latin America optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 42 Latin America actuators market, by product 2014 - 2025 (USD Million)
Table 43 Latin America sensors market, by product 2014 - 2025 (USD Million)
Table 44 Latin America optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 45 Brazil optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 46 Brazil actuators market, by product 2014 - 2025 (USD Million)
Table 47 Brazil sensors market, by product 2014 - 2025 (USD Million)
Table 48 Brazil optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 49 MEA optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 50 MEA actuators market, by product 2014 - 2025 (USD Million)
Table 51 MEA sensors market, by product 2014 - 2025 (USD Million)
Table 52 MEA optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 53 South Africa optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 54 South Africa actuators market, by product 2014 - 2025 (USD Million)
Table 55 South Africa sensors market, by product 2014 - 2025 (USD Million)
Table 56 South Africa optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 1 Global number of DALY’s for neurological disorders for 2005, 2015, & 2030
Table 2 Optogenetic studies of neurodegenerative diseases
Table 3 Transgenic mouse lines expressing optical activators or silencers
Table 4 List of the latest GEVI’s apt for cardiac in vivo studies
Table 5 North America optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 6 North America actuators market, by product 2014 - 2025 (USD Million)
Table 7 North America sensors market, by product 2014 - 2025 (USD Million)
Table 8 North America optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 9 U.S. optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 10 U.S. actuators market, by product 2014 - 2025 (USD Million)
Table 11 U.S. sensors market, by product 2014 - 2025 (USD Million)
Table 12 U.S. optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 13 Canada optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 14 Canada actuators market, by product 2014 - 2025 (USD Million)
Table 15 Canada sensors market, by product 2014 - 2025 (USD Million)
Table 16 Canada optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 17 Europe optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 18 Europe actuators market, by product 2014 - 2025 (USD Million)
Table 19 Europe sensors market, by product 2014 - 2025 (USD Million)
Table 20 Europe optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 21 Germany optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 22 Germany actuators market, by product 2014 - 2025 (USD Million)
Table 23 Germany sensors market, by product 2014 - 2025 (USD Million)
Table 24 Germany optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 25 U.K. optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 26 U.K. actuators market, by product 2014 - 2025 (USD Million)
Table 27 U.K. sensors market, by product 2014 - 2025 (USD Million)
Table 28 U.K. optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 29 Asia Pacific optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 30 Asia Pacific actuators market, by product 2014 - 2025 (USD Million)
Table 31 Asia Pacific sensors market, by product 2014 - 2025 (USD Million)
Table 32 Asia Pacific optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 33 Japan optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 34 Japan actuators market, by product 2014 - 2025 (USD Million)
Table 35 Japan sensors market, by product 2014 - 2025 (USD Million)
Table 36 Japan optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 37 China optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 38 China actuators market, by product 2014 - 2025 (USD Million)
Table 39 China sensors market, by product 2014 - 2025 (USD Million)
Table 40 China optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 41 Latin America optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 42 Latin America actuators market, by product 2014 - 2025 (USD Million)
Table 43 Latin America sensors market, by product 2014 - 2025 (USD Million)
Table 44 Latin America optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 45 Brazil optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 46 Brazil actuators market, by product 2014 - 2025 (USD Million)
Table 47 Brazil sensors market, by product 2014 - 2025 (USD Million)
Table 48 Brazil optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 49 MEA optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 50 MEA actuators market, by product 2014 - 2025 (USD Million)
Table 51 MEA sensors market, by product 2014 - 2025 (USD Million)
Table 52 MEA optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
Table 53 South Africa optogenetics actuators & sensors market, by product, 2014 - 2025 (USD Million)
Table 54 South Africa actuators market, by product 2014 - 2025 (USD Million)
Table 55 South Africa sensors market, by product 2014 - 2025 (USD Million)
Table 56 South Africa optogenetics actuators & sensors, by disease type, 2014 - 2025 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research patternra
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market summary
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping for methods, 2016
Fig. 13 SWOT Analysis, By Factor (Political & legal, economic, and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Global optogenetics actuators & sensors market: Product outlook key takeaways
Fig. 16 Global optogenetic actuators & sensors market: Product movement analysis
Fig. 17 Global actuators market, 2014 - 2025 (USD Million)
Fig. 18 Global channelrhodopsin market, 2014 - 2025 (USD Million)
Fig. 19 Global halorhodopsin market, 2014 - 2025 (USD Million)
Fig. 20 Global archaerhodopsin market, 2014 - 2025 (USD Million)
Fig. 21 Global sensors market, 2014 - 2025 (USD Million)
Fig. 22 Global genetically encoded calcium indicators market, 2014 - 2025 (USD Million)
Fig. 23 Global voltage-sensitive fluorescent proteins market, 2014 - 2025 (USD Million)
Fig. 24 Global pH sensors market, 2014 - 2025 (USD Million)
Fig. 25 Global optogenetic actuators & sensors market: Disease type estimates outlook key takeaways
Fig. 26 Global optogenetic actuators and sensors market: Disease type movement analysis
Fig. 27 Global retinal disorders market, 2014 - 2025 (USD Million)
Fig. 28 Global parkinson’s disease market, 2014 - 2025 (USD Million)
Fig. 29 Global anxiety & depression market, 2014 - 2025 (USD Million)
Fig. 30 Global autism market, 2014 - 2025 (USD Million)
Fig. 31 Global schizophrenia market, 2014 - 2025 (USD Million)
Fig. 32 Global others market, 2014 - 2025 (USD Million)
Fig. 33 Regional market place: Key takeaway
Fig. 34 Global optogenetics actuators & sensors market regional outlook, 2016 & 2025
Fig. 35 North America optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 36 U.S. optogenetic actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 37 Canada optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 38 Europe optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 39 Germany optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 40 U.K. optogenetic actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 41 Asia Pacific optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 42 Japan optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 43 China optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 44 Latin America optogenetic actuators & sensors market, 2014-2025 (USD Million)
Fig. 45 Brazil optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 46 Middle East & Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 47 South Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 48 List of companies
Fig. 49 Strategy framework
Fig. 50 Participant categorization
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research patternra
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market summary
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping for methods, 2016
Fig. 13 SWOT Analysis, By Factor (Political & legal, economic, and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Global optogenetics actuators & sensors market: Product outlook key takeaways
Fig. 16 Global optogenetic actuators & sensors market: Product movement analysis
Fig. 17 Global actuators market, 2014 - 2025 (USD Million)
Fig. 18 Global channelrhodopsin market, 2014 - 2025 (USD Million)
Fig. 19 Global halorhodopsin market, 2014 - 2025 (USD Million)
Fig. 20 Global archaerhodopsin market, 2014 - 2025 (USD Million)
Fig. 21 Global sensors market, 2014 - 2025 (USD Million)
Fig. 22 Global genetically encoded calcium indicators market, 2014 - 2025 (USD Million)
Fig. 23 Global voltage-sensitive fluorescent proteins market, 2014 - 2025 (USD Million)
Fig. 24 Global pH sensors market, 2014 - 2025 (USD Million)
Fig. 25 Global optogenetic actuators & sensors market: Disease type estimates outlook key takeaways
Fig. 26 Global optogenetic actuators and sensors market: Disease type movement analysis
Fig. 27 Global retinal disorders market, 2014 - 2025 (USD Million)
Fig. 28 Global parkinson’s disease market, 2014 - 2025 (USD Million)
Fig. 29 Global anxiety & depression market, 2014 - 2025 (USD Million)
Fig. 30 Global autism market, 2014 - 2025 (USD Million)
Fig. 31 Global schizophrenia market, 2014 - 2025 (USD Million)
Fig. 32 Global others market, 2014 - 2025 (USD Million)
Fig. 33 Regional market place: Key takeaway
Fig. 34 Global optogenetics actuators & sensors market regional outlook, 2016 & 2025
Fig. 35 North America optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 36 U.S. optogenetic actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 37 Canada optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 38 Europe optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 39 Germany optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 40 U.K. optogenetic actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 41 Asia Pacific optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 42 Japan optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 43 China optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 44 Latin America optogenetic actuators & sensors market, 2014-2025 (USD Million)
Fig. 45 Brazil optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 46 Middle East & Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 47 South Africa optogenetics actuators & sensors market, 2014 - 2025 (USD Million)
Fig. 48 List of companies
Fig. 49 Strategy framework
Fig. 50 Participant categorization
